NJ Bio, Inc. reposted this
There has been significant development of Targeted Protein Degraders like #PROTACs and #MolecularGlues in the therapeutic space. This innovative modality is carving out a new market by addressing the limitations of small molecule inhibitors, especially for hard-to-treat cancers and neurodegenerative disorders. As the field continues to grow, staying updated is crucial for making informed research decisions and refining your drug development approach. NJ Bio has compiled a comprehensive review on the latest trends and developments in TPD research. Download it for free from https://lnkd.in/gFVd-P7u